The News, Remastered
1 satirical articles about biotech acquisition on Hambry. Updated live.
The Acquisition, Valued at $400 Million, Marks a Bold New Frontier in Completely Unproven Cross-Industry Synergy.
Stay in the Loop
100+
Articles/Day
—
Followers
